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Jane Povey a, Andrew Dean b, Sarah J. Turner b, Colin M. Jaques b, Robert J. Young c, 
Andrew J. Racher b, C. Mark Smales a,* 
a Industrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, Kent CT2 7NJ, UK 
b Lonza Biologics, 228 Bath Road, Slough, SL1 4DX, UK 
c Cell Engineering Group, Lonza Biologics, Chesterford Research Park, Building 200, Little Chesterford, CB10 1XL, UK   
A R T I C L E  I N F O   
Keywords: 
Chinese hamster ovary (CHO) cells 
Metabolic selection system 
Cell engineering 
Proline metabolism 
Biotherapeutic protein production 
A B S T R A C T   
Chinese hamster ovary (CHO) cells are the leading mammalian cell host employed to produce complex secreted 
recombinant biotherapeutics such as monoclonal antibodies (mAbs). Metabolic selection marker technologies (e. 
g. glutamine synthetase (GS) or dihydrofolate reductase (DHFR)) are routinely employed to generate such re-
combinant mammalian cell lines. Here we describe the development of a selection marker system based on the 
metabolic requirement of CHO cells to produce proline, and that uses pyrroline-5-carboxylase synthetase (P5CS) 
to complement this auxotrophy. Firstly, we showed the system can be used to generate cells that have growth 
kinetics in proline-free medium similar to those of the parent CHO cell line, CHOK1SV GS-KO™ grown in proline- 
containing medium. As we have previously described how engineering lipid metabolism can be harnessed to 
enhance recombinant protein productivity in CHO cells, we then used the P5CS selection system to re-engineer 
lipid metabolism by over-expression of either sterol regulatory element binding protein 1 (SREBF1) or stearoyl 
CoA desaturase 1 (SCD1). The cells with re-engineered proline and lipid metabolism showed consistent growth 
and P5CS, SCD1 and SREBF1 expression across 100 cell generations. Finally, we show that the P5CS and GS 
selection systems can be used together. A GS vector containing the light and heavy chains for a mAb was super- 
transfected into a CHOK1SV GS-KO™ host over-expressing SCD1 from a P5CS vector. The resulting stable 
transfectant pools achieved a higher concentration at harvest for a model difficult to express mAb than the 
CHOK1SV GS-KO™ host. This demonstrates that the P5CS and GS selection systems can be used concomitantly to 
enable CHO cell line genetic engineering and recombinant protein expression.   
1. Introduction 
Recombinant protein drugs are manufactured using a range of 
expression systems. Chinese hamster ovary (CHO) cells are the expres-
sion system most widely used to produce complex human-like recom-
binant proteins such as monoclonal antibodies (mAbs) (Walsh, 2018). As 
such, a kaleidoscope of processes and technologies required for the 
generation and purification of recombinant material from CHO cells has 
been explored to improve productivity, ensure consistent product 
quality and reduce process timelines (Vito et al., 2020; Povey et al., 
2014; Pekle et al., 2019; Shukla et al., 2018; Budge et al., 2021). Yet 
there remains a need and desire to further improve such expression 
systems, particularly for so termed difficult to express (DTE) proteins 
(Roobol et al., 2020). 
Selection markers and the type of marker are a key technology for 
isolating CHO cells expressing transgenes of interest and ensuring their 
continued expression with increasing cell age. Initially, the markers 
were eukaryotic proteins e.g. neomycin phosphotransferase that 
allowed the transfected cell to grow in the presence of the cognate 
antibiotic. There are problems with antibiotic-based selection systems: 
antibiotics can alter host cell gene expression that may impact produc-
tivity yields and/or product quality (Ryu et al., 2017), mask low-level 
contamination with adventitious agents, the antibiotic itself is a 
contaminant in the manufacturing process (Mignon et al., 2015; Davies, 
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1996) that must be removed from the drug substance, and their use is 
not desirable in a GMP facility due to the health risks arising from po-
tential cross-contamination. 
An alternative approach to antibiotic selection is to use metabolic 
selection markers. Dihydrofolate reductase (DHFR) (Kaufman and 
Sharp, 1982a; Jossé et al., 2018) and glutamine synthetase (GS) (Cockett 
et al., 1990; Birch et al., 2008) are well established examples of meta-
bolic selection. DHFR reduces dihydrofolate to produce tetrahy-
drofolate, a vitamin required as a precursor for de novo synthesis of 
essential molecules such as hypoxanthine and thymidine (Kaufman and 
Sharp, 1982b). In the absence of exogenous hypoxanthine or thymidine 
DHFR-deficient CHO host cells are unable to survive. However, intro-
duction and expression of the DHFR gene can restore the ability of a cell 
to produce sufficient tetrahydrofolate and, in turn, hypoxanthine and 
thymidine therefore enabling cells to survive with no external source of 
these essential molecules. Similarly, GS is the enzyme responsible for the 
conversion of glutamate to glutamine. CHO glutamine-auxotrophs, 
usually created by the inhibition of endogenous GS by methionine sul-
foximine (MSX) (Feary et al., 2017) or knockout of endogenous GS (Fan 
et al., 2012), are unable to survive in a glutamine-free environment. 
However, by introducing an exogenous glutamine synthetase (GLUL) 
gene cells can produce sufficient glutamine to survive without an 
external glutamine source (Bebbington et al., 1992). The auxotrophic 
nature of CHO cells based around the inability to produce hypoxanthine 
and thymidine or glutamine has enabled exploitation of DHFR and GLUL 
genes respectively to select for stably expressing cells. As outlined 
above, in order to improve the selection stringency of both of these 
systems, inhibitors are often introduced to the culture medium which 
inactivate the enzymatic function of the selection gene. Methotrexate 
(MTX) and MSX are used to inhibit the activity of DHFR or GS respec-
tively, and only cells expressing appropriate amounts of these enzymes 
to overcome the inhibitory concentrations are able to grow. 
The DHFR and GS systems are well established in industry for the 
generation of recombinant biotherapeutic protein producing CHO cell 
lines. However, with the development of more complex non-natural 
molecules made from multiple gene products together with interest in 
synthetic biology approaches for the engineering of production hosts to 
enhance their ability to produce higher amounts and quality of proteins, 
there is a need to develop additional, non-antibiotic based metabolic 
selection systems. This would allow the engineering of host cells using 
one selection marker whilst leaving the GS or DHFR selection marker 
available to subsequently generate and select for recombinant bio-
therapeutic protein producing cells. A further application of new 
metabolic markers would be for the development of improved bio-
processes that do not require particular metabolites to be present in 
medium or feed, simplifying the bioprocess. Indeed, there have been a 
number of reports of such alternative selection systems. For example, 
Zhang et al. reported the development of a double auxotrophic selection 
system based on knockout of two enzymes involved in pyrimidine and 
purine biosynthesis and utilised these for selection and isolation of cell 
lines expressing a model Fc-fusion and mAb molecule (Zhang et al., 
2020). In a different approach, Capella Roca et al. have reported the 
development of an arginase based selection system for CHO cell hosts 
lacking arginase activity (Roca et al., 2019). Very recently, Sun et al. 
reported a proline based metabolic selection system used to isolate GFP 
and mAb expressing recombinant CHO cell lines, and although the mAb 
titres were not high by industrial standards (approximately 3.4 μg/ml) 
they were comparable to those achieved from antibiotic selection sys-
tems including zeocin (2.25 μg/ml) and G418 (1.65 μg/ml) based sys-
tems (Sun et al., 2020). We note that the high mAb titres achieved 
industrially with other metabolic selection systems (e.g. DHFR, GS) have 
access to, and utilise, highly optimised host cells, expression vectors, and 
inhibitors to improve selection stringency alongside refined culture 
processes. Typically, media for sustaining mammalian cell growth 
contain proline because such cells (including CHO strains derived from 
CHO–K1) are unable to synthesise sufficient proline to sustain necessary 
cellular processes such as de novo protein synthesis required to support 
rapid cell proliferation (Sahu et al., 2016). 
Here we describe the development of a pyrroline-5-carboxylase 
synthetase gene selection marker system, application of P5CS in-
hibitors to the selection process and its application to the engineering of 
lipid metabolism in CHO cells. Pyrroline-5-carboxylase synthetase 
(P5CS) is a key enzyme involved in the synthesis of proline from 
glutamate (Pérez-Arellano et al., 2010). Expression of transgenic P5CS 
allows cells with sufficient P5CS to synthesise the required amounts of 
proline from glutamate to survive in the absence of exogenous proline, 
thus facilitating selection of desired cells. We then successfully 
employed the selection system to facilitate genetic over-expression en-
gineering of either sterol regulatory element binding protein 1 (SREBF1) 
or stearoyl CoA desaturase 1 (SCD1) lipid modifying genes in the 
CHOK1SV GSKO™ host cell line. We have previously shown how 
manipulation of these lipid-altering genes can improve cellular pro-
cesses involved in recombinant therapeutic expression (Budge et al., 
2019, 2020). Importantly, we show that the utilisation of the P5CS based 
system does not affect the subsequent use of the GS based selection 
system to generate recombinant biotherapeutic expressing CHO cell 
lines producing industrially relevant amounts of recombinant protein. 
This shows that the P5CS and GS systems can be used concurrently to 
enable CHO cell line genetic engineering and recombinant bio-
therapeutic protein cell line construction processes. 
2. Methods 
2.1. Vector construction 
The CgPICR_007864 gene (for P5CS) was obtained by commercial 
synthesis (GeneArt, ThermoFisher Scientific, USA) such that the amino 
acid sequence shared 100% identity with the CHO cell derived se-
quences (accession number XM_007631963.2). The nucleotide sequence 
was based upon the corresponding mRNA sequence (XM_003508062.2) 
with a small number of nucleotides changed to facilitate subsequent 
cloning ensuring that the amino acid sequence was not altered. The gene 
was cloned into Lonza proprietary expression vectors using BglII and 
NheI restriction enzymes such that expression of the gene is driven by an 
SV40 promoter. A combination of Gibson Assembly (NEB) and restric-
tion cloning was used, as per the manufacturer’s instructions, to 
generate vectors which comprised the P5CS expression cassette in 
combination with expression cassettes for either eGFP, stearoyl CoA 
desaturase (SCD1) or sterol regulatory element binding factor 1 
(SREBF1). The source of the SCD1 and SREBF1 genes has been previ-
ously described (Budge et al., 2019). Different promoters, considered by 
the authors to give relatively low (PGK promoter), mid (SV40 promoter) 
or high (mCMV) transcriptional activity, were employed to drive 
different levels of expression of the SCD1 and SREBF1 genes. The mCMV 
promoter was consistently employed to drive eGFP gene expression. 
2.2. Mammalian cell culture 
The Lonza CHOK1SV GSKO™ host cell line (a GS knockout cell line 
with no endogenous GS expression) was used exclusively throughout 
this study. Cell concentrations and culture viability data were deter-
mined using a ViCell (Beckman Coulter) instrument. The medium used 
was either commercial Gibco CD-CHO medium (ThermoFisher Scienti-
fic) or Medium A (Lonza proprietary medium) as described in the text. 
Bespoke L-proline-free CD-CHO based medium was prepared by Ther-
moFisher Scientific. For routine culture, suspension cultures were 
seeded at 0.2 × 106 viable cells/ml in 20 ml in a 125 ml Erlenmeyer 
flasks (Corning) and incubated at 37 ◦C. For 96 deep well plate experi-
ments, these were cultured at 37 ◦C in a total volume of 300 μl per well. 
Cells were also grown in an Ambr®15 platform (Sartorius Stedim 
Biotech) using a proprietary fed-batch process for GS-CHO cell lines 
(Lonza). 
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2.3. Occurrence of spontaneous revertants 
To determine an estimate of the frequency with which spontaneous 
proline-independent revertants occur, 96 well plates were seeded at 
either 5000 or 1000 viable cells per well in a volume of 200 μl in 
different media. Fifteen plates at each cell concentration were seeded in 
either CD-CHO medium supplemented with 6 mM L-glutamine, CD-CHO 
with no L-glutamine or Medium A supplemented with L-glutamine and 
lacking L-proline. The number of colonies (defined as an obvious group 
of cells clustered in an area) that grew was determined by visual in-
spection using a light microscope, and the result expressed as a per-
centage of total cells seeded. 
2.4. Electroporation to transfect plasmid DNA into cells 
Electroporation was used to introduce vector DNA into CHO cells. 
The DNA solution, 20 μg of DNA in 100 μl of TE buffer, was mixed with 1 
× 107 viable cells in 700 μl of culture medium using a 4 mm electro-
poration cuvette (BioRad). A pulse was applied using the exponential 
protocol on a GenePulser Xcell electroporator (Bio-Rad) instrument at 
300 V and 900 μF. 
2.5. Cell line construction 
Vector DNA constructs (50 μg) for cell line construction were line-
arised using the PvuI (NEB) restriction enzyme as previously described 
(Budge et al., 2019). Linearised DNA (20 μg) was then transfected into 
the CHOK1SV GS-KO™ host cell line as in section 2.4. Transfected cells 
were then transferred to static T75 flasks and sufficient medium added 
to give a total volume of 20 ml of the appropriate medium (e.g. L-pro-
line-free medium was used to generate cell pools using a construct 
bearing the CgPICR_007864S gene). 
2.6. P5CS inhibitors 
L-Azetidine-2-carboxylic acid (Sigma A0760) and 3,4-Dehydro-L-pro-
line (Sigma D4893) are known inhibitors of P5CS and were evaluated in 
the proline based selection system (Fig. 4). The compounds were dis-
solved directly in proline-free Medium A (Lonza) to achieve the desired 
concentration. A range of concentrations (between 1 and 20 mM) were 
initially screened (data not shown, when inhibitor concentrations were 
too high cells did not survive beyond the 24 h timepoint) in order to 
select the concentrations used to evaluate the inhibitors. The initial 
concentration range was selected based on the working concentration of 
ornithine (an analogue of both inhibitors) which has previously been 
reported to be effective in inhibiting P5CS activity at 5 mM (Hu et al., 
1999). 
2.7. Western blot analysis 
Total cell protein was extracted from cell pellets by chemical lysis 
using a lysis buffer supplemented with protease inhibitors as previously 
described (Roobol et al., 2014). SDS-PAGE was subsequently used to 
resolve polypeptides from these lysates. Proteins were then transferred 
to a nitrocellulose membrane and blocked for 30 min in a 5% (w/v) 
powdered milk solution made up in 0.2% Tween TBS. Anti-SCD1 (Cell 
Signalling 2438), anti-SREBP1 (Abcam ab3259 or Fisher MA511685 
SREBP-1 (2A4) Mouse Monoclonal Antibody), anti-P5CS (anti--
ALDH18A1; Sigma HPA012604) and anti-α-tubulin (a kind gift from Prof 
K. Gull (Roobol et al., 2009)) primary antibodies were used. Anti-mouse 
HRP peroxidase (Sigma A4416) or anti-rabbit HRP peroxidase (Sigma 
A6154) secondary antibody conjugates were employed as appropriate to 
detect the relevant polypeptides via chemiluminescence using Hyper-
film ECL reagents (GE Healthcare). Densitometry was carried out using 
ImageJ software. 
2.8. Dot blot analysis 
Proteins were extracted from cell pellets (section 2.6) and lysate 
samples drawn through a nitrocellulose membrane using Bio-dot appa-
ratus (BioRad). Anti-SREBP1 (Abcam ab3259), anti-P5CS (anti- 
ALDH18A1; HPA012604) or anti-β-actin (Sigma A5441) were exposed to 
the membrane. Anti-mouse HRP peroxidase (Sigma A4416) or anti- 
rabbit HRP peroxidase (Sigma A6154) secondary antibody conjugates 
were employed to facilitate relevant polypeptide detection via chem-
iluminescence using Hyperfilm ECL reagents (GE Healthcare). 
2.9. Genomic DNA extraction and quantitative PCR 
Genomic DNA extractions were carried out using a PureLink 
Genomic DNA Mini Kit (Invitrogen) following the manufacturer’s in-
structions. Quantitative PCR was carried out on 50 ng genomic DNA 
using Qiagen QuantiFast SYBR Green RT-PCR kits as per instructions 
provided by the manufacturer. The primers used to quantify exogenous 
CgPICR_007864 (for P5CS), SCD1 and SREBF1 are shown in Table 1. 
Forward primers were designed to the different promoters (PGK or 
SV40) used to drive exogenous expression of SCD1 or SREBF1 in order to 
distinguish between exogenous and endogenous sequences present in 
the engineered cell genomes. 
2.10. Confocal microscopy 
Coverslips were coated with poly-L-lysine (molecular weight 
70,000–150,000 (P4707), Sigma Aldrich, USA) by submerging the 
coverslip for 15 min in a well of a 24 well plate and subsequently rinsed 
with water and left to air dry for 1 h. Cells were seeded at 2 × 105 viable 
cells/ml where 1 ml was placed in each well onto the pre-treated cov-
erslips. These were incubated statically for 1 h at 37 ◦C and 5% CO2 to 
allow cells to adhere to the coverslip before the medium was aspirated 
and cells fixed by adding 250 μl 4% (w/v) paraformaldehyde in PBS and 
subsequently permeabilised using 0.1% (v/v) Triton-X in PBS. 
Fig. 1. Growth profiles showing viable cell concentration and culture viability 
of CHOK1SV GSKO™ cells in CD-CHO medium including L-proline and L- 
glutamine (complete) or L-proline-free or L-glutamine-free medium. Solid lines 
show the viable cell concentration whilst broken lines show culture viabilities. 
Batch cultures were seeded at 0.2 × 10 (Budge et al., 2021) viable cells/ml in a 
total culture volume of 20 ml and cell concentrations measured using a ViCell 
every 24 h. The value at 0 h was calculated based on the concentration used to 
set up the initial cultures. N = 3 for each data point and error bars represent ±
one standard deviation. 
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Coverslips were transferred to 25 μl drops of anti-P5CS antibody (anti- 
ALDH18A1; HPA012604) diluted in 3% (w/v) BSA in PBS and incubated 
overnight. Four washes, each 5 min long, were carried out using 0.1% 
(v/v) Tween in PBS before exposing to anti-rabbit TRITC antibody 
(1:100). A further 4 washes were carried out as before and coverslips 
were transferred to 50 μl drops of DAPI (10 mg/ml) and washed a final 3 
times. Finally, cells were mounted using ProLong Gold mounting agent 
on a glass slide before examination using a Zeiss LSM 880/Elyra/Axio 
Observer Z1 confocal microscope. 
2.11. Flow cytometry 
Cells were harvested and then the pellets resuspended in PBS. Sam-
ples were analysed using a FACScalibur (BD Biosciences) and fluores-
cence intensity was measured using the FL-1 detector at 473 (Au). The 
E− 1 amplifier was used to collect forward scatter (FSC) and side scatter 
(SSC) was set to 465 (Au). Thresholds were set such that events recorded 
below 550 FSC or SSC were not collected as part of the final analysis. 
2.12. Quantification of secreted antibody production 
Recombinant molecule concentrations in cell culture supernatants 
were determined using an Octet® instrument (ForteBio) with IgG cali-
brators and protein A biosensors. 
3. Results 
3.1. Culture of CHOK1SV GS-KO™ host cell line in L-proline-free 
medium 
We initially tested the CHOK1SV GSKO cell line to confirm the ex-
pected proline auxotrophic phenotype of this CHO cell line given its 
lineage (Kao and Puck, 1967). The CHOK1SV GSKO™ host cell line was 
grown in batch culture in CD-CHO complete medium (with L-glutamine 
and L-proline), CD-CHO medium with no L-glutamine or medium with 
no L-proline. Fig. 1 shows the resulting growth profile of the cell cultures 
under these conditions over 168 h where cell concentration and culture 
viability were determined every 24 h. The CHOK1SV GSKO™ host cell 
line is engineered to knockout glutamine synthetase expression, which 
has previously been shown as essential for CHO cell growth and survival 
in the absence of exogenous L-glutamine (Nakamura and Omasa, 2015). 
As expected, cells grown in the presence of both L-proline and L-gluta-
mine (complete medium) showed a typical batch-culture growth profile 
over the 168 h of culture, reaching a viable cell concentration of 
approximately 14 × 106 cells/ml and maintaining a culture viability 
close to 100% across the culture (Fig. 1). Cells cultured in the absence of 
L-glutamine did not grow and the viability of these cultures dropped as 
expected such that by the end culture viability was <10%. As expected, 
cells cultured in the absence of L-proline showed almost no growth 
compared to the control, reaching a maximum cell concentration of 0.3 
× 106 cells/ml. Culture viability declined albeit at a slower rate 
compared to L-glutamine-free medium (Fig. 1). Both these observations 
are in agreement with that expected based on the report of Kao and Puck 
(1967) who showed that in the absence of proline CHO cells had 
virtually no growth whilst viability was initially maintained for 2–3 days 
Fig. 2. Initial recovery of CHOK1SV GSKO™ cells 
transiently transfected with vectors bearing either 
GS, CgPICR_007864 (for P5CS) or no (Control) se-
lection genes as well as the eGFP reporter gene. 
Cells were transfected on day 0 and data was 
collected 7 days after transfection having been 
cultured in the specified medium. Comp (complete) 
medium contained glutamine and proline, ‘no glut’ 
had no glutamine present in the medium, ‘no pro’ 
had no proline present in the medium. Viable cell 
concentration (A) and culture viability (B) were 
determined using a ViCell instrument whilst geo-
metric mean fluorescence (C) was determined using 
flow cytometry. N = 3 and error bars represent ±
one standard deviation.   
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but then decreased with a half-life of 1.3 days. 
As Kao and Puck also showed that spontaneous revertants to proline 
independence could arise when cells were cultured in the absence of 
proline, the frequency of occurrence of proline-independent revertants 
was determined (Section 2.3). The estimated frequency for occurrence 
of revertants in the absence of proline was 17.4 colony formations per 
107 cells plated (data not shown). This compares to that reported by Kao 
and Puck (1967) of 24 colonies from 1.12 × 107 cells and a spontaneous 
reversion rate of approximately 1 × 10− 6. Thus, our findings are in line 
with those previously reported although we note that the previous 
studies contained 2% fetal calf serum and were grown in a different 
medium. This reversion frequency compares to a reversion rate of 0 in 
the absence of L-glutamine because the introduced GLUL deletions in the 
2 alleles of the CHOK1SV GSKO™ host cell line are over-lapping and 
out-of-frame. Thus, as expected given its provenance, CHOK1SV 
GSKO™ can be considered as a functional proline auxotroph. 
3.2. Expression of exogenous P5CS restores growth of CHOK1SV 
GSKO™ cells in L-proline-free medium 
We next undertook transient expression studies to determine (1) 
whether overexpression of P5CS was able to restore the growth attri-
butes of the CHOK1SV GSKO™ host cell in L-proline-free culture media, 
and (2) the effect upon subsequent transient recombinant protein 
expression. A vector containing the genes for CgPICR_007864 (for P5CS) 
and eGFP was constructed to facilitate these studies. An additional 
control vector, a negative control vector with the same basic vector 
structure but lacking both the selection gene and the eGFP reporter gene 
was also used. These vectors are referred to as ‘P5CS’ and ‘control’ 
respectively. The CHOK1SV GSKO™ host was transfected with the 
different vectors and cells subsequently cultured in either complete, no 
L-glutamine or no L-proline media (Fig. 2). Cells transfected with any 
one of the vectors achieved higher viable cell concentrations in complete 
medium (containing L-glutamine and L-proline) than their counterparts 
cultured in the absence of either L-glutamine or L-proline (Fig. 2A). 
The resulting data confirmed that exogenous expression of P5CS 
confers the ability of cells to both survive and grow in L-proline-free 
medium. Cells transfected with the CgPICR_007864 containing vector 
obtained higher viable cell concentrations when cultured without L- 
proline, than when transfected with the control vector. An increase in 
culture viability (Fig. 2B) and geometric mean fluorescence (Fig. 2C) 
was observed when using the P5CS vector in combination with the 
medium lacking L-proline compared to the control vector in L-proline- 
free medium. The geometric mean was used as it is more robust and less 
sensitive to outliers than the arithmetic mean. The data suggest that 
transient overexpression of P5CS is able to restore growth characteristics 
in cells where no exogenous L-proline is available. Presumably this is 
enabled through synthesis of additional L-proline (see section 3.7 for 
confirmation of this). This increase in viable cell concentration, culture 
viability and fluorescence was only observed with the CgPICR_007864/ 
Fig. 3. Analysis of cell pools generated through overexpression of P5CS and cultured in L-proline-free medium. Cell cultures were analysed using flow cytometry (A). 
Fluorescent confocal microscopy was also undertaken where blue = DAPI, red = P5CS:TRITC, green = eGFP (B and C). Figure B shows an image (where all channels 
are overlaid) of cells generated using the P5CS/proline selection system and Figure C shows a comparison between P5CS/proline generated pools and the GSKO host. 
(For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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L-proline-free medium combination suggesting that the CgPICR_007864 
gene was expressed to sufficient amounts to restore loss of cellular 
functions observed when L-proline is removed. Cells cultured in the 
absence of L-proline achieved a substantially lower maximum viable cell 
concentration in L-proline-free medium compared to complete medium 
(Fig. 2A). As previously observed and described in Fig. 1, cells grown in 
the absence of L-proline had very limited growth, albeit achieving a 
higher viable cell concentrations than when cultured without L-gluta-
mine (compare No Pro with No Glut, Fig. 2A). 
3.3. Stable CHOK1SV GSKO™ recombinant protein expressing cell pools 
can be produced using P5CS as a metabolic selection marker 
Following the demonstration that cell growth alongside enhanced 
Fig. 4. Analysis of cell pools generated using 
exogenous P5CS expression. Cells selected by 
culturing transfected cells in L-proline-free Medium 
A were transferred to media supplemented with 
known P5CS inhibitors added at a variety of 
different concentrations and cultured in static 24 
well plates for 9 days. Cells cultured in the presence 
of L-azetidine-2-carboxylic acid (red) were analysed 
for viable cell concentration (A) and culture 
viability (B). Cells were also analysed by flow 
cytometry to determine geometric mean cell fluo-
rescence (C) and the percentage of cells exceeding a 
predetermined fluorescence threshold (D). In addi-
tion cells were cultured in the presence of 3,4- 
dehydro-L-proline (blue) and analysed for viable 
cell concentration (E) and culture viability (F). Cells 
were also analysed using flow cytometry to deter-
mine geometric mean cell fluorescence (G) and the 
percentage of cells exceeding a predetermined 
fluorescence threshold (H). N = 3 and error bars 
show ± one standard deviation. (For interpretation 
of the references to colour in this figure legend, the 
reader is referred to the Web version of this article.)   
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survival rates could be achieved in a short, transient setting following 
introduction of the CgPICR_007864 gene, we carried out further studies 
to determine whether the P5CS based selection system was suitable for 
stable cell pool construction. To achieve this the vector containing the 
CgPICR_007864 and eGFP genes was linearised and transfected into the 
Lonza CHOK1SV GSKO™ host cell line. Cells were then left to recover in 
L-proline-free medium in a static incubator for a total of 14 days before 
transferring to 20 ml suspension cultures in 125 ml Erlenmeyer flasks. 
Fig. 3 shows analysis of the resulting cell pools constructed using the 
P5CS system described. Flow cytometry was used to measure fluores-
cence arising from eGFP expression in the cell pools; a clear population 
of cells with high fluorescence was observed (Fig. 3A). Since cells were 
gated such that hosts expressing no eGFP did not exceed 101 fluores-
cence intensity, it is apparent that those cells exceeding this threshold 
had a higher fluorescence intensity due to the expression of eGFP. 
Analysis of the cell pool constructed using the P5CS selection system 
showed that some cells within the population did not exceed the fluo-
rescence intensity threshold indicating that they did not express eGFP at 
detectable levels. Approximately 43% of the cells in the pool population 
exceeded the pre-set fluorescence intensity threshold. 
The cell pool population was also analysed for eGFP and P5CS 
expression using confocal microscopy imaging (Fig. 3B and C). This 
analysis again confirmed eGFP expression in the population. The cells 
expressing eGFP also showed an increased P5CS expression in the pool 
transfected with the P5CS and eGFP construct compared to the GSKO 
control host cell pool (Fig. 3C). The analysis of P5CS expression also 
indicated the localisation of P5CS in CHO cells whereby punctate spots 
representative of P5CS were observed that are consistent with previous 
literature showing that P5CS is present in mitochondria (Pérez-Arellano 
et al., 2010). 
3.4. Addition of P5CS inhibitors to recombinant stable cell pools 
constructed with the P5CS/proline selection system enriches the stringency 
of selection 
We next investigated whether the use of inhibitors of the P5CS 
enzyme could improve the stringency of the selection system in a 
manner similar to that by which addition of MSX or MTX can improve 
the selection stringency of the GS and DHFR selection systems respec-
tively. In order to investigate this, inhibitors of P5CS enzyme activity 
were used to determine if the presence of these would increase the 
stringency of the selection system (i.e. level of metabolic marker 
expression required for a transfected cell to survive in the selective 
environment resulting in death of both non-transfected cells and cells 
with low level expression of the selectable marker). In theory, by 
downregulating P5CS activity and therefore proline synthesis only those 
cells with higher exogenous P5CS expression would be able to survive, 
grow and proliferate in L-proline-free medium. Fig. 4 shows the analysis 
of the cell pool constructed above (Fig. 3) and grown in the presence of a 
range of concentrations of the P5CS inhibitors L-azetidine-2-carboxylic 
acid (Fig. 4A–D) or 3,4-dehydro-L-proline (Fig. 4E–H) added into L- 
proline-free medium A at inoculation of the cultures. We note that whilst 
L-azetidine-2-carboxylic acid may be misincorporated into polypeptides 
in place of proline (Samardzic and Rodgers, 2019) which is undesirable 
and potentially toxic, to our knowledge 3,4-dehydro-L-proline is not 
highly toxic which is a further potential benefit of using this inhibitor. 
Determination of viable cell concentrations and culture viability plus 
analysis by flow cytometry fluorescence were carried out at 48, 120 and 
192 h post supplementation whereby cultures were initially seeded at 
0.2 × 106 viable cells/ml in static 24 well plates. The resulting data show 
that both L-azetidine-2-carboxylic acid and 3,4-dehydro-L-proline 
reduced the estimate of maximum viable cell concentration (value at 
120 h), reduced overall culture viability but increased the percentage of 
cells expressing eGFP and the overall geometric mean fluorescence 
(Fig. 4). This suggests that inhibition of P5CS activity was able to in-
crease the stringency of the P5CS selection system over a 192 h time 
period. Furthermore, the effect of the chosen inhibitors was concentra-
tion dependent in that higher concentrations of inhibitor generally 
increased the geometric mean fluorescence of the culture the most 
(Fig. 4D and H) and reduced viable cell concentration of the pool the 
most (Fig. 4A and E). Whilst geometric mean fluorescence increased 
with increasing L-azetidine-2-carboxylic acid concentration in all cases, 
for 3,4-dehydro-L-proline the geometric mean fluorescence of the pop-
ulation increased when supplemented with 2.5 or 5 mM but the use of 
10 mM resulted in a decrease in mean fluorescence when compared to 5 
mM (Fig. 4H). In summary, 10 mM L-azetidine-2-carboxylic acid and 5 
mM 3,4-dehydro-L-proline were the most effective concentrations 
evaluated for improving P5CS selection system stringency over the time 
period analysed. 
3.5. Use of P5CS/proline selection in engineering of lipid biosynthesis in 
the CHOK1SV GSKO™ host cell line 
Following the successful demonstration that the P5CS/proline sys-
tem could be used to select for cells expressing a model protein, we 
employed the system to engineer lipid metabolism in the CHOK1SV 
GSKO™ host cell line. We used the system to select for cells stably 
overexpressing two different lipid metabolism modifying (LMM) genes, 
SCD1 and SREBF1. We have previously shown that overexpression of 
these genes in a CHO cell host can change lipid metabolism, expand the 
ER of CHO cells and enhance productivity of biotherapeutic protein 
molecules such as mAbs (Budge et al., 2019). We therefore attempted to 
engineer CHOK1SV GSKO™ cell pools to overexpress these two LMM by 
transfecting vectors containing the CgPICR_007864 (for P5CS) gene, to 
facilitate selection, and either the SCD1 or SREBF1 genes (where 
expression was driven by different promoters compared to the 
CgPICR_007864 gene) into the host and subsequently allowing the cells 
to recover in L-proline-free CD-CHO medium. The transfected cells were 
plated out to create minipools (i.e. transfected cells were distributed 
across 96 well plates such that each well contained 10,000 transfected 
cells). Since the optimal expression level of the LMM genes was un-
known, inhibitors to improve stringency were not employed during this 
construction process thus potentially allowing cells with a range of P5CS 
and LMM expression levels to recover to facilitate evaluation of lower 
and higher expressing cells alike. 
The resulting minipools generated were analysed via dot blot to 
determine the relative levels of LMM protein expression (Supplementary 
Figure 1 shows examples of dot blots obtained). The minipools were 
then ranked based on the relative amounts of the LMM protein expressed 
(within the range generated from specific constructs) and 20 of those 
with similar expression levels as determined by dot blot combined to 
generate a ‘low’, ‘mid’ and ‘high’ expressing pool. Fig. 5 shows western 
blot analysis of cell lysates generated from cells from each of these pools. 
Whilst the CHOK1SV GSKO™ control host showed no detectable levels 
of P5CS protein by western blot, the pools all showed expression of the 
P5CS protein confirming that over-expression had been achieved in the 
arising cell pools (Fig. 5). Furthermore, the western blot analysis 
confirmed that the application of the P5CS selection system had resulted 
in the isolation of pools overexpressing the target LMM molecules as 
shown by increased SCD1 and precursor SREBF1 protein expression 
levels in the high pools (Fig. 5). This provides clear evidence that the 
P5CS system can be used in CHO cells without the use of inhibitors to 
isolate cells expressing target exogenous genes that reside within the 
Table 1 
Primers used for analysis of genomic CgPICR_007864 DNA.  
Gene Name Forward Primer (5’ – 3′) Reverse Primer (5’ – 3′) 
CgPICR_007864 (P5CS) ccccatggctgactaatttt gacagctgaaggctggactc 
PGK-SCD1 cattctgcacgcttcaaaag tggtggtggtcgtgtaagaa 
PGK-SREBF1 cattctgcacgcttcaaaag tgagctgaagcatgtcttgg 
SV40-SREBF1 ccccatggctgactaatttt tgagctgaagcatgtcttgg  
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same genetic construct. 
3.6. LMM engineered CHOK1SV GSKO™ cell pools generated using the 
P5CS based selection system show stability for at least 100 generations 
Generating recombinant engineered cell pools and lines able to 
sustain a consistent and high expression of exogenous target genes over 
long periods of time is an ongoing challenge for industry (Dahodwala 
and Lee, 2019). Selection systems employed for generating engineered 
and recombinant CHO cell lines must be evaluated for their capacity to 
maintain prolonged stability of exogenous gene expression. With this in 
mind, we assessed the long-term stability of the P5CS/proline based 
system employed here in terms of both the selectable marker P5CS and 
the exogenous SCD1 and SREBF1 LMM genes introduced using this se-
lection system. The engineered cell pools were maintained in L-proli-
ne-free CD-CHO medium (Gibco) over 100 generations where cells were 
harvested and lysed at 0 and 100 generations (generation or population 
doubling number (n) calculated as n = (log cell number of subculture - 
log seeding cell number of subculture)/log (2) + x where x = generation 
number of culture used for seeding). Fig. 6A shows batch culture growth 
profiles of SCD1 engineered cells from generation 0 and 100 that were 
run simultaneously after revival from cryostorage. Supplementary 
Table 1 reports the IVC, maximum viable cell concentration, growth rate 
and doubling time for all SCD1 and SREBF1 pools. Importantly, the 
batch culture growth profiles of cells after 100 generations showed no 
marked change compared to those from generation 0 (Supplementary 
Table 1), indicating that the ability to grow in L-proline-free medium 
was consistent over 100 generations. Further evidence of the maintained 
growth profiles is illustrated in Supplementary Figure 2 which reports 
addition cell pool G0 and G100 growth profiles. 
Analysis was also carried out on protein lysates harvested at gener-
ation 0 and 100 (G0 and G100) to compare expression levels of SCD1 or 
SREBF1 between these generations. Fig. 6B shows western blot analysis 
of P5CS, SCD1 and SREBF1 expression where α-tubulin was used as a 
loading control. The relative levels of the P5CS selection marker are 
similar between the respective G0 and G100 samples and between 
different cell pools, indicating the stability of P5CS expression over time. 
This was also the case for the low and mid-SREBF1 pools (Fig. 6B). For 
the highest expressing SREBF1 pools (SV40 SREBF1 High) there was a 
change in banding pattern between G0 and G100 samples (Fig. 6B), 
consistent with previous studies, suggesting that high levels of SREBF1 
are not maintained due to lipotoxicity associated with overproduction of 
cellular lipids brought about by upregulation of SREBF1 (Kliewer et al., 
1997; van Herpen and Schrauwen-Hinderling, 2008). On western blots 
for the SCD1 protein for G100 samples a lower band was observed in 
addition to the single higher band observed in G0 samples (Fig. 6B). It is 
likely that the double SCD1 band observed in G100 samples of SCD1 
overexpressing pools was due to inherent lipid metabolism regulatory 
processes which have been reported to occur later in subculture (Hei-
nemann and Ozols, 1998). In this case, samples were taken during 
routine passaging which occurred 3 days after seeding for G0 samples 
and 4 days after seeding for G100 samples. 
In addition to analysis at the protein level, qPCR was carried out on 
genomic DNA isolated from G0 and G100 cultures samples taken at the 
same time as the protein lysate samples. Fig. 6C shows the ratio of 
relative P5CS:LMM gene copies, where LMM refers either to SCD1 or 
SREBF1 depending on which gene was being overexpressed in the 
respective pool. These data show that the ratio of the selection marker 
(P5CS) and the recombinant target (LMM) was consistent with 
increasing cell age for almost all of the cell pools evaluated. It is notable 
that PGK SREBF1 High 1, SV40 SREBF1 High 2 and SV40 SREBF1 Low 1 
samples suggest either a decrease in P5CS or increase in LMM copies 
between G0 and G100. Since the protein levels of P5CS were remarkably 
consistent, this is consistent with this increase in ratio being due to a 
reduction in SREBF1. Conversely, the PGK SREBF1 Low 2 sample showed 
results consistent with an upregulation of the SREBF1. Collectively, the 
data described in this section show that the P5CS/proline system has the 
capacity to select for stably expressing P5CS cells that maintain their 
growth phenotype and to maintain cell pools overexpressing the target 
LMM genes over 100 generations. We note these experiments were 
conducted using minipools and thus will be more susceptible to varia-
tion than clonal cell lines and selection pressure was only maintained by 
removing L-proline from medium without the addition of inhibitors. 
3.7. Generation and analysis of monoclonal SCD1 engineered CHOK1SV 
GSKO™ cell lines from P5CS selected pools 
We have previously shown, using an alternative antibiotic based 
selection marker, that genetic engineering to modify lipid metabolism 
by over-expression of SCD1 or SREBF1 can be employed in CHO cells to 
increase recombinant product yields (Budge et al., 2019, 2020). In the 
present study, the P5CS/proline selection system was used to genetically 
engineer the CHOK1SV GSKO™ host cell line through overexpression of 
the SCD1 gene as an exemplar of the system as our previous study 
showed SCD1 over-expression tended to give greater enhancement of 
recombinant protein production than SREBF1. Engineered pools were 
isolated that overexpress SCD1 to different levels in order to find the 
SCD1 overexpression level that maximises productivity. We initially 
assessed minipools of SCD1 or SREBF1 engineered CHOK1SV GSKO™ 
cells for their ability to transiently express a model Fc-fusion protein and 
what the authors consider a difficult to express mAb in a 96 deep well 
plate format. From these data, the top 15 minipools, in terms of the 
Fc-fusion protein and mAb expression were stably transfected, using GS 
selection, with the two test molecules and then the productivity of the 
resulting pools assessed in an Ambr15® fed-batch experiment (data not 
shown). Cells from the 5 minipools across the original SCD1 and SREBF1 
P5CS engineered hosts that gave the highest mAb and Fc-fusion protein 
titre were then isolated by limited dilution cloning. Thus, clonal host cell 
lines expressing SCD1 or SREBF1, but not the model proteins, were 
obtained from the cell pools that gave the highest secreted product 
Fig. 5. Western blot analysis of CHOK1SV GSKO™ cells engineered to over-
express either SCD1 or SREBF1 using the P5CS/proline selection system. The 
cells were ranked for levels of LMM expression and pooled in order to generate 
low, mid and high overexpressing pools. Western blots have been appropriately 
exposed to antibodies to indicate bands associated with P5CS, SCD1 and 
SREBF1 where α-tubulin was used as a loading control (since SCD1 and SREBF1 
were probed on different blots, separate loading controls from each blot have 
been included as indicated). 
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concentrations (data not shown). The resulting cell lines were then again 
assessed for their ability to transiently express model recombinant 
proteins in a 96 DWP. The top 15 clonal cell lines were then progressed 
for further analysis. Fig. 7A shows western blot analysis carried out on 
these clones to evaluate the relative amounts of P5CS and SCD1 
expressed using α-tubulin as a loading control. As expected, the levels of 
P5CS and SCD1 vary between the clones: Fig. 7B shows the relationship 
between the relative levels of SCD1 and P5CS for each clone as deter-
mined by densitometry. As these were cell lines with different promoters 
driving SCD1 expression, P5CS expression was always driven by the 
same promoter and there was a narrow range of P5CS and SCD1 
expression in the selected cell lines (Fig. 7B) it is not surprising that there 
was no evidence for a correlation between P5CS and SCD1 protein 
expression (Pearson correlation coefficient = 0.10). 
In Fig. 7B the densitometry analysis of western blot bands of cell lines 
8, 9, 14 and 15 is highlighted. These were the best performing of the cell 
lines evaluated in terms of transient recombinant protein expression 
yields (data not shown). Further analysis of these clones was therefore 
carried out to confirm these cells were able to synthesise their own 
proline requirements by measuring the proline concentrations in spent 
medium after 15 days of fed-batch culture in an Ambr15 instrument 
using L-proline-free Medium A and a Lonza proprietary feeding regime 
(Fig. 7C). The results show that all of the cell lines were able to syn-
thesise proline and that for 3 of the 4 SCD1 engineered cell lines the 
concentration of proline detected in the spent medium was approxi-
mately 4-6-fold higher than in the spent medium of the CHOK1SV 
GSKO™ host cultured using medium containing the standard amount of 
L-proline. The other SCD1 engineered host had a similar amount of 
proline in the spent medium compared to that in the control host. These 
data confirm that the SCD1 engineered cells were able to produce 
endogenous proline, presumably due to the presence of the P5CS gene 
which facilitates cell survival and growth. Indeed, 3 of the cell lines 
Fig. 6. Assessment of the long term stability of 
CHOK1SV GSKO™ cells engineered to overexpress 
the SCD1 and SREBF1 LMM genes using the PSCS/ 
proline selection system. (A) Engineered cells were 
maintained for 100 generations with cells passaged 
every 3–4 days in L-proline free medium and batch 
culture experiments were run to compare cells 
derived from the 1st (G0) and 100th generation 
(G100). The growth profiles were determined by 
measuring the viable cell concentration of cell pools 
across batch culture. Control cell pools were 
generated using constructs containing the P5CS se-
lection marker with no additional gene (fx). Cell 
pools overexpressing SCD1 were constructed with a 
vector containing both the P5CS selection marker 
and SCD1 gene where expression was driven by a 
PGK promoter and pools considered either rela-
tively high (fx) or low (fx) overexpression levels. 
Two independeht pools were monitored and these 
are distinguished by either an open marker or file 
d marker. Solid lines show “GO” and broken lines 
show “G100′′ cultures. (B) Western blot analysis of 
cell lysate samples harvested from cells at GO and 
G100 for P5CS, SCD1 and SREBF1 protein expres-
sion where α-tubulin was used as a loading control. 
As SCD1 and SREBF1 were probed for on different 
blots, separate loading controls from each blot have 
been included as indicated. (C) Quantitative PCR 
was carried out to compare gene copy numbers of 
cell pools from GO (grey bars) or G100 (black bars). 
The ratio of P5CS:LMM gene copies (GCN - gene 
copy number) was determined from data obtained 
from each timepoint. Samples 1 and 2 refer to bio-
logical repeats and promotors, LMM and relative 
overexpression levels are labelled accordingly.   
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appear to produce much more proline than required by the cell as evi-
denced by the high concentrations observed in the spent media. The 
levels of glutamate, a precursor in the biosynthesis of proline, were also 
determined and are reported in Fig. 7C. All the SCD1 engineered clones 
generated using the P5CS selection system had lower levels of glutamate 
in the spent medium compared to the control host, suggesting that the 
cells utilise glutamate to synthesise proline via the P5CS selection sys-
tem. Thus, where higher levels of proline were observed, lower levels of 
glutamate were detected. 
3.8. The GS selection system can be used in conjunction with the P5CS 
proline based selection system to generate cells engineered to overexpress 
SCD1 and to produce a model difficult to express biotherapeutic 
monoclonal antibody 
It is critical that any selection strategies used to engineer CHO cells to 
introduce genes that will improve the desired characteristics of the host 
cell line is compatible with selection strategies used to subsequently 
select for cells producing a recombinant product in the engineered host. 
As such, an established commercially relevant cell line construction 
workflow at Lonza which utilises the GS selection system was applied to 
the four SCD1 engineered cell lines 8, 9, 14 and 15 (Section 3.7) to 
generate cell pools expressing a clinically relevant model recombinant 
monoclonal antibody product considered difficult to express (DTE) by 
the authors. The top 10 expressing minipools for each cell line, as 
determined by Protein A Octet analysis at the 96 DWP scale, were then 
pooled together. These new minipools were subsequently grown up into 
shake flasks and then grown under fed-batch culture conditions in an 
Ambr®15 bioreactor system in L-proline-free Medium A and the con-
centration of secreted antibody in the cell culture supernatant at the end 
of culture determined by Protein A Octet analysis. Fig. 8 and Supple-
mentary Table 2 report the product concentrations obtained from the 
pools originating from the different host cell lines. Importantly, the data 
show that the GS selection system can be used subsequent to, and on top 
of, the P5CS selection system to generate recombinant monoclonal 
antibody secreting cell pools that produce as well, if not better, than the 
original non-engineered cell line (Fig. 8). The cell specific productivity 
(Qp) was increased in all SCD1 engineered pools compared to the con-
trol CHOK1SV GSKO™ host, further confirming that over-expression of 
SCD1 can enhance cell specific and overall productivity from CHO cells 
and that this can be achieved using P5CS selection. Thus, overall these 
data show that P5CS can be used to engineer CHO cells without inter-
fering with subsequent cell line construction using the established GS 
selection system. Increased product yields were also achieved from LMM 
engineered cells which is consistent with previous studies showing that 
overexpression of SCD1 can improve recombinant antibody 
Fig. 7. Analysis of isolated SCD1 engineered cell lines constructed using the 
P5CS selection system. Western blot analysis was used to determine the relative 
abundance of P5CS and SCD1 present in cell lysates of isolated cell lines 
engineered to overexpress SCD1 where expression was driven by different 
promoters and α-tubulin was used as a loading control (A). Densitometry 
analysis was carried out on western blots to quantify the relative amounts of 
SCD1 and P5CS where both were normalised to the appropriate α-tubulin band. 
The relative abundance of SCD1 and P5CS were plotted against each other 
where an “x" shows samples where promoter A was used to drive SCD1 
expression, "•" shows where promoter B has been used and “fx” shows where 
promoter C has been used. The cell lines which were selected for further 
evaluation are identified using a grey shape and labelled with the appropriate 
cell line number (B). The concentrations of proline and glutamate in spent 
culture media were recorded after 15 days of culture with the specified 
clones (C). 
Fig. 8. Difficult to express (DTE) monoclonal antibody product concentrations 
from cell pools generated using the GS expression system where engineered 
clones overexpressing SCD1 (established using the P5CS selection system) were 
used as the host for cell pool construction as shown on the x axis. Each bar 
shows the product concentration values from a cell pool construction process 
where the top 10 yielding minipools were pooled and an established fed-batch 
production protocol in an Ambr15® used to assess product yields from the 
resulting combined pool. The secondary axis shows the relative abundance of 
SCD1 as determined using data in Fig. 7 where the data points are denoted by 
circles in line with the appropriate titre data for each cell line. The CHOK1SV 
GSKO™ host and GS selection for the isolation of antibody expressing pools was 
used to compare against the performance of SCD1 engineered host cells selected 
using the P5CS system. 
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concentrations from CHO cells (Budge et al., 2019). 
4. Discussion 
As outlined in the introduction, selection marker technologies are 
routinely employed to generate recombinant mammalian cell lines 
producing a range of biotherapeutic protein molecules of interest. After 
a lack of developments over the last several decades there has been an 
upsurge of interest with a number of groups reporting the recent 
development of alternatives to GS and DHFR metabolic selection sys-
tems for use in CHO cells (Kaufman and Sharp, 1982a; Jossé et al., 2018; 
Cockett et al., 1990; Birch et al., 2008). Additional selection systems also 
allow for the engineering and maintenance of host cell systems to 
improve, or introduce new, cellular attributes whilst leaving, for 
example, the traditional GS and DHFR systems available for the subse-
quent introduction of a target biopharmaceutical. Here, the ability of the 
P5CS/proline system to be employed for cell line engineering has also 
been demonstrated, being used to select for cells overexpressing the lipid 
metabolism modifying genes SCD1 and SREBF1. Further, we have pre-
viously described how the SCD1 enzyme, that converts saturated fatty 
acids to monounsaturated fatty acids, can be overexpressed to enhance 
recombinant protein productivity (Budge et al., 2019). We were able to 
replicate this result using the P5CS selection system to engineer the 
CHOK1SV GSKO™ host cell line and subsequently use the engineered 
host to generate cell pools using the established GS system expressing 
industrially relevant amounts of a difficult to express monoclonal anti-
body. The compatibility of these systems together has great potential in 
cell line engineering but may also be utilised for production of materials 
where it is necessary to express multiple genes. Additionally, the P5CS 
engineering of the cells removes the need to provide L-proline in the cell 
culture medium and therefore has implications for media development 
and bioprocessing. Such an ability to engineer host cells also opens the 
opportunity to remove medium components that can be problematic 
during bioprocessing or change metabolism to prevent the accumulation 
of toxic growth inhibitors as demonstrated by others who engineered 
CHO cell phenylalanine-tyrosine and branched chain amino acid 
biosynthesis to prevent the build-up of such growth inhibiting com-
pounds so that it was not necessary to add tyrosine to the culture media 
(Mulukutla et al., 2019). 
The studies described here outline development and validation of a 
selection system centred around proline synthesis, showing its successful 
implementation and the stability of the system over long-term culture to 
provide a selective advantage (i.e. the ability to grow in L-proline-free 
medium) to CHO cells expressing recombinant genes of interest. The 
fundamental basis of the selection system relies on the overexpression of 
the gene for P5CS combined with the use of L-proline-free culture me-
dium to enrich a cell population expressing a desirable second (or 
additional) exogenous gene located on the same construct as the gene for 
P5CS. Whilst we have shown that this system can be successfully 
employed simply by removing exogenous L-proline from the culture 
medium, we have also successfully demonstrated the utility of inhibitors 
of the P5CS enzyme to improve selection stringency. A crucial finding in 
this study is that the cells selected using this system exhibit very similar 
growth profiles in comparison to the parental host (cultured with 
exogenous L-proline) and are able to proliferate in the absence of L- 
proline over more than 100 generations. This allows for sustained se-
lection pressure in culture simply by removing exogenous L-proline and 
means that the selection method is compatible with existing processes 
beyond cell line construction. 
Finally, it is essential that a selection system designed to generate 
high producing recombinant cell lines is able to sustain stable and high 
production levels over time. Knockout of endogenous GS in CHO cell 
hosts has proved successful in enhancing selection stringency and this 
increases the likelihood of selecting a superior clone (Dahodwala and 
Lee, 2019; Jun et al., 2006; Chusainow et al., 2009). We have shown that 
overexpression of a transgene in cell pools generated from P5CS 
engineered hosts were maintained across 100 generations in the ma-
jority of pools investigated. Whilst expression levels in cell pools may be 
subject to fluctuation over time due to their heterogeneous nature, 
monoclonal cell lines are likely to exhibit increased stability. We 
observed low P5CS expression amounts in native CHO host cells, in 
agreement with a previous study by Sun et al. that also demonstrated 
that knockout of the P5CS gene can improve the stringency of a proline 
based selection system (Sun et al., 2020). We have shown that enhanced 
stringency can be achieved without knockout when supplementing 
culture medium with appropriate inhibitors of the P5CS enzyme 
(L-azetidine-2-carboxylic acid or 3-4-dehydro-L-proline) and therefore 
use of such inhibitors can improve stringency without the need for P5CS 
knockout. A combination of the P5CS knockout strategy and addition of 
the inhibitors outlined here could provide the selection system with 
additional stringency. 
Collectively, the data presented here demonstrate that the P5CS 
proline selection system can be used for the isolation of cells that grow in 
the absence of exogenous L-proline with a growth profile similar to that 
of the original host. Further the system can be used to introduce exog-
enous gene function to CHO cells that is stable under continued selection 
based upon the absence of L-proline in the culture media, and that such 
engineered host cells can subsequently be used to generate stably 
expressing biotherapeutic protein cell pools based upon GS selection 
technology at industrially relevant levels. In this aspect our study differs 
from that of Sun et al. who utilised the P5CS system to directly select for 
biotherapeutic mAb production whereas we have combined two meta-
bolic selection systems to (a) firstly utilise the P5CS system to engineer 
the proline AND lipid metabolism of the cell and then (b) use the GS 
selection system to select for high biotherapeutic expressing cells. 
Although we observed no obvious differences in product quality be-
tween biotherapeutic proteins produced from the original CHOK1SV 
GSKO™ host or the SCD1 engineered hosts selected via the P5CS system, 
whether the engineered systems impact such critical quality attributes 
could be evaluated further in the future. 
In summary, we have successfully designed and implemented a 
P5CS/proline based system for the selection of recombinant CHO cells 
under industrially relevant conditions. The system is effective in its 
current format and inhibitors have been identified which have the po-
tential to improve selection stringency further alongside introduction of 
additional exogenous genes using alternative, existing selection strate-
gies such as the GS selection technology. The development of such 
systems opens up new opportunities in the engineering biology field to 
engineer CHO cells further, and impact bioprocesses, to enhance the 
ability of such expression systems to produce current, new and novel 
format biopharmaceutical candidates at higher yield and quality than 
currently achievable. 
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Pérez-Arellano, I., Carmona-Álvarez, F., Martínez, A.I., Rodríguez-Díaz, J., Cervera, 
2010. J. Pyrroline-5-carboxylate synthase and proline biosynthesis: from 
Osmotolerance to rare metabolic disease. Protein Sci. 19, 372–382. 
Povey, J.F., et al., 2014. Rapid high-throughput characterisation, classification and 
selection of recombinant mammalian cell line phenotypes using intact cell MALDI- 
ToF mass spectrometry fingerprinting and PLS-DA modelling. J. Biotechnol. 184, 
84–93. 
Roca, B.C., Lao, N., Barron, N., Doolan, P., Clynes, M., 2019. An arginase-based system 
for selection of transfected CHO cells without the use of toxic chemicals. J. Biol. 
Chem. 294, 18756–18768. 
Roobol, A., Carden, M.J., Newsam, R.J., Smales, C.M., 2009. Biochemical insights into 
the mechanisms central to the response of mammalian cells to cold stress and 
subsequent rewarming. FEBS J. 276, 286–302. 
Roobol, A., et al., 2014. The chaperonin CCT interacts with and mediates the correct 
folding and activity of three subunits of translation initiation factor eIF3: b, i and h. 
Biochem. J. 458, 213–224. 
Roobol, A., et al., 2020. Engineered transient and stable overexpression of translation 
factors eIF3i and eIF3c in CHOK1 and HEK293 cells gives enhanced cell growth 
associated with increased c-Myc expression and increased recombinant protein 
synthesis. Metab. Eng. 59, 98–105. 
Ryu, A.H., Eckalbar, W.L., Kreimer, A., Yosef, N., Ahituv, N., 2017. Use antibiotics in cell 
culture with caution: genome-wide identification of antibiotic-induced changes in 
gene expression and regulation. Sci. Rep. 7, 7533. 
Sahu, N., et al., 2016. Proline starvation induces unresolved ER stress and hinders 
mTORC1-dependent tumorigenesis. Cell Metabol. 24, 753–761. 
Samardzic, K., Rodgers, K.J., 2019. Cell death and mitochondrial dysfunction induced by 
the dietary non-proteinogenic amino acid l-azetidine-2-carboxylic acid (Aze). Amino 
Acids 51, 1221–1232. 
Shukla, A.A., Rameez, S., Wolfe, L.S., Oien, N., 2018. High-throughput process 
development for biopharmaceuticals. In: Advances in Biochemical Engineering/ 
Biotechnology, vol. 165. Springer Science and Business Media Deutschland GmbH, 
pp. 401–441. 
Sun, T., et al., 2020. Development of a proline-based selection system for reliable genetic 
engineering in Chinese hamster ovary cells. ACS Synth. Biol. 2020, 1864–1872. 
van Herpen, N.A., Schrauwen-Hinderling, V.B., 2008. Lipid accumulation in non-adipose 
tissue and lipotoxicity. Physiol. Behav. 94, 231–241. 
Vito, D., et al., 2020. Defining lncRNAs correlated with CHO cell growth and IgG 
productivity by RNA-seq. iScience 23, 100785. 
Walsh, G., 2018. Biopharmaceutical benchmarks 2018. Nat. Biotechnol. 36, 1136–1145. 
Zhang, Q., Jiang, B., Du, Z., Chasin, L.A., 2020. A doubly auxotrophic CHO-K1 cell line 
for the production of recombinant monoclonal antibodies. Biotechnol. Bioeng. 117, 
2401–2409. 
J.D. Budge et al.                                                                                                                                                                                                                                
